Detalles de la búsqueda
1.
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
Int J Cancer
; 143(2): 333-342, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29453769
2.
Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
BMC Infect Dis
; 18(1): 38, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29334901
3.
[HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples]. / Test HPV primario nello screening per il cervicocarcinoma: valutazione della riproducibilità e indagine sull'esito citologico dei campioni borderline al test Hybrid Capture 2.
Epidemiol Prev
; 40(3-4): 164-70, 2016.
Artículo
en Italiano
| MEDLINE | ID: mdl-27436249
4.
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
J Med Virol
; 87(3): 508-15, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25418873
5.
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.
J Clin Microbiol
; 51(9): 2901-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23804385
6.
A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
BMC Infect Dis
; 13: 74, 2013 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23390953
7.
Assessment of the feasibility of pool testing for SARS-CoV-2 infection screening.
Infect Dis (Lond)
; 54(7): 478-487, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239458
8.
Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme.
J Med Screen
; 29(2): 110-122, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038279
9.
Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samples.
PLoS One
; 16(5): e0251589, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003878
10.
HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.
J Clin Virol
; 76 Suppl 1: S22-S28, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26669512
11.
Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
J Cancer Res Clin Oncol
; 142(1): 201-12, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26210155
12.
Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
J Clin Virol
; 60(3): 257-63, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815381
13.
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.
Hum Vaccin Immunother
; 9(7): 1407-12, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23571176
14.
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.
Infect Agent Cancer
; 7(1): 26, 2012 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23110797
15.
Distribution of high and low risk HPV types by cytological status: a population based study from Italy.
Infect Agent Cancer
; 6: 2, 2011 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21247508
16.
Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
Cancer Epidemiol Biomarkers Prev
; 19(9): 2389-400, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20826836
Resultados
1 -
16
de 16
1
Próxima >
>>